Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Current Assets (2019 - 2025)

Pulmonx (LUNG) has disclosed Current Assets for 7 consecutive years, with $123.9 million as the latest value for Q1 2025.

  • On a quarterly basis, Current Assets fell 16.22% to $123.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was $123.9 million, a 16.22% decrease, with the full-year FY2024 number at $136.2 million, down 9.42% from a year prior.
  • Current Assets was $123.9 million for Q1 2025 at Pulmonx, down from $136.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $233.1 million in Q2 2021 to a low of $123.9 million in Q1 2025.
  • A 5-year average of $169.7 million and a median of $166.7 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: dropped 18.77% in 2022, then decreased 9.42% in 2024.
  • Pulmonx's Current Assets stood at $208.0 million in 2021, then decreased by 18.77% to $169.0 million in 2022, then dropped by 10.97% to $150.4 million in 2023, then decreased by 9.42% to $136.2 million in 2024, then decreased by 9.03% to $123.9 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Current Assets are $123.9 million (Q1 2025), $136.2 million (Q4 2024), and $147.9 million (Q1 2024).